T-Net9m
Zucara Therapeutics Announces Strategic Investment from Big Pharma Giant Sanofi as Part of US $20 Million Series B Financing
Zucara Therapeutics Inc., a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that ...
The Pharma Letter52m
European R&D spend outpaced by USA – with increasing China competition
New research published by the European Federation of Industries and Associations (EFPIA) provides in-depth analysis of the ...
The Pharma Letter53m
Research concerns remain as Denmark targets care reform
Denmark's health reform targets chronic disease care, health inequalities, and innovation, with measures like chronic care ...